AVID BIOSERVICES DL-001
Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stabilit… Read more
AVID BIOSERVICES DL-001 (TEHP) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, AVID BIOSERVICES DL-001 (TEHP) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
AVID BIOSERVICES DL-001 - Net Assets Trend (None–None)
This chart illustrates how AVID BIOSERVICES DL-001's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for AVID BIOSERVICES DL-001 (None–None)
The table below shows the annual net assets of AVID BIOSERVICES DL-001 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to AVID BIOSERVICES DL-001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
AVID BIOSERVICES DL-001 Competitors by Market Cap
The table below lists competitors of AVID BIOSERVICES DL-001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Rai Way SpA
LSE:0R40
|
$580.07 Million |
|
Argosy Property Limited
PINK:IGPYF
|
$580.19 Million |
|
Aoshikang Technology Co Ltd Class A
SHE:002913
|
$580.25 Million |
|
Beijing Jingcheng Machinery Electric Co Ltd
SHG:600860
|
$580.38 Million |
|
Tianjin Benefo Tejing Electric Co Ltd
SHG:600468
|
$579.34 Million |
|
Chengdu Spaceon Electronics Co Ltd Class A
SHE:002935
|
$579.10 Million |
|
UniTTEC Co Ltd
SHE:000925
|
$578.87 Million |
|
Tesna Inc
KQ:131970
|
$578.78 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in AVID BIOSERVICES DL-001's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares AVID BIOSERVICES DL-001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently AVID BIOSERVICES DL-001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares AVID BIOSERVICES DL-001's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| AVID BIOSERVICES DL-001 (TEHP) | €- | N/A | N/A | $579.75 Million |
| Hanna Capital Corp (04U1) | $-79.29K | 0.00% | 0.00x | $116.52K |
| WESTMINSTER RES (08W) | $4.66 Million | -31.33% | 0.12x | $5.16 Million |
| Axonics Inc (0I3) | $570.14 Million | -10.47% | 0.16x | $3.29 Billion |
| Global Bioenergies SA (1DK) | $14.81 Million | -86.04% | 0.89x | $369.68K |
| GIEAG Immobilien AG (2GI) | $41.80 Million | 40.21% | 8.93x | $15.57K |
| 2invest AG (2INV) | $82.61 Million | -2.29% | 0.06x | $13.67 Million |
| PT Central Proteina Prima Tbk (4PT) | $3.42 Trillion | 11.74% | 1.00x | $6.90 Million |
| DGH Deutsche Grundwert Holding AG (5TR) | $0.00 | 0.00% | 0.00x | $18.45K |
| SOFTCHOICE CORP. (90Q) | $58.23 Million | -19.76% | 10.01x | $470.36 Million |
| ALBA SE (ABA) | $142.95 Million | 5.25% | 0.45x | $5.10 Million |